SCHEMBL1940345

SCHEMBL1940345

COc1ccc2c(CC#N)noc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.45
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
CHRNA7 P36544 2/20 0.39
HTR3A P46098 2/20 0.39
HSD17B10 Q99714 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
TSHR P16473 1/20 0.39
HBB P68871 1/20 0.39
CYP2D6 P10635 2/20 0.38
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 3/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
POLB P06746 1/20 0.38
STAT1 P42224 1/20 0.38
HPGD P15428 1/20 0.37
MEN1 O00255 1/20 0.37
GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9246318 0.89 NPC1 (0.45) ACHEHSD17B10CYP2D6KDM4EALDH1A1
SCHEMBL11789849 0.88 ACHE (0.45) ACHEHSD17B10L3MBTL1TSHRHBB
SCHEMBL9244949 0.81 KDM4E (0.50) ACHEHSD17B10TSHRCYP2D6KDM4E
SCHEMBL26083923 0.80 ACHE (0.47) ACHECHRNA7HTR3AHSD17B10L3MBTL1
SCHEMBL15158081 0.75 MAPT (0.56) ACHEHSD17B10KDM4EALDH1A1MAPT
SCHEMBL5178348 0.73 L3MBTL1 (0.44) HSD17B10L3MBTL1TSHRHBBKDM4E
SCHEMBL10397074 0.73 LMNA (0.53) ACHEL3MBTL1KDM4EALDH1A1NPC1
SCHEMBL8140185 0.73 CHRNA7 (0.45) ACHECHRNA7HTR3AHSD17B10L3MBTL1
SCHEMBL6990724 0.73 BRD4 (0.49) CHRNA7HTR3AHSD17B10L3MBTL1KDM4E
SCHEMBL11790366 0.72 ACHE (0.42) ACHECHRNA7HTR3AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173679-B2 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents LABORATOIRE THERMAMEX (MC) 2012-05-08 US disclosed
US-20110237624-A1 INDAZOLES, BENZISOXAZOLES AND BENZISOTHIAZOLES AND THEIR USE AS ESTROGENIC AGENTS LABORATOIRE THERAMEX (MC) 2011-09-29 US disclosed
US-7977364-B2 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents LABORATOIRE THERMAMEX (MC) 2011-07-12 US disclosed
EP-1812404-B1 INDAZOLES, BENZISOXAZOLES AND BENZISOTHIAZOLES AND THEIR USE AS ESTROGENIC AGENTS THERAMEX (MC) 2011-06-15 EP disclosed
US-20090023779-A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents LABORATOIRE THERAMEX (FR) 2009-01-22 US disclosed
EP-1647549-A1 Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents LABORATOIRE THERAMEX (MC) 2006-04-19 EP disclosed
US-3948928-A ANTI-RESERPINE, CNS DEPRESSANT, HYPOTENSIVE, L-DOPA POTENTIATORS DAINIPPON PHARMACEUTICAL CO., LTD. (JA) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023779-A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents ESR1, ESR2, GPER1 ACHE 1147/4885ESR1 1/4885ESR2 2/4885
US-20110237624-A1 INDAZOLES, BENZISOXAZOLES AND BENZISOTHIAZOLES AND THEIR USE AS ESTROGENIC AGENTS ESR1, ESR2, GPER1 ACHE 1147/4885ESR1 1/4885ESR2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.